Autoimmune hepatitis in patients aged 70 years or older: Disease characteristics, treatment response and outcome.

Georgios N DalekosKalliopi AzariadisVasiliki LygouraPinelopi ArvanitiStella GampetaNikolaos K Gatselis

Published in: Liver international : official journal of the International Association for the Study of the Liver (2021)

AIH should be seriously considered in patients ≥70 y with unexplained impaired liver function tests as the disease is not infrequent in this group and seems to bear an increased risk for advanced disease stage at diagnosis. However, if immunosuppression is started promptly, it seems as safe and effective as in younger patients.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
peritoneal dialysis
multiple sclerosis
patient reported outcomes
patient reported